Analysis of tumor‐bearing brains revealed that targeting TAGLN expression in GSCs reduced the expression levels of TAGLN, the proliferation marker Ki67, and the GSC marker SOX2, but increased levels of the GFAP differentiation marker and Cleaved Caspase3 (Figure 4L; Figure S4K, Supporting Information). Here, SOX2 is linked to neoplasm.